Black men with metastatic castration-resistant prostate cancer (CRPC) who received hormonal therapy with the adrenal inhibitor abiraterone had greater and longer-lasting responses compared with white men, according to the results of a lat
Original Article: Abiraterone May Be More Effective in Black Men With Prostate Cancer